Recent News

• 09.16.2025 - Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
• 09.16.2025 - Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
• 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.04.2025 - Cantor Global Healthcare Conference
• 09.04.2025 - Cantor Global Healthcare Conference
• 09.02.2025 - Stoke Therapeutics and Biogen Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome
• 09.02.2025 - Stoke Therapeutics and Biogen Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome
• 08.28.2025 - Stoke Therapeutics to Present at Upcoming Investor Conferences in September 2025
• 08.28.2025 - Stoke Therapeutics to Present at Upcoming Investor Conferences in September 2025

Recent Filings

• 09.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.02.2025 - 144 Report of proposed sale of securities
• 08.29.2025 - 144 Report of proposed sale of securities
• 08.29.2025 - 144 Report of proposed sale of securities
• 08.26.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership